These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 3958686

  • 1. Systemic reaction to pyrimethamine-sulfadoxine.
    Murphy RL, Phair JP.
    J Fam Pract; 1986 Apr; 22(4):375-6. PubMed ID: 3958686
    [No Abstract] [Full Text] [Related]

  • 2. Fatal hepatic necrosis due to pyrimethamine-sulfadoxine (Fansidar).
    Zitelli BJ, Alexander J, Taylor S, Miller KD, Howrie DL, Kuritsky JN, Perez TH, Van Thiel DH.
    Ann Intern Med; 1987 Mar; 106(3):393-5. PubMed ID: 2949680
    [Abstract] [Full Text] [Related]

  • 3. [Drug-induced hepatitis caused by Fansidar].
    Gersch K, Bröker HJ, Mörl H, Waldherr R.
    Schweiz Med Wochenschr; 1987 Oct 03; 117(40):1544-8. PubMed ID: 3118458
    [Abstract] [Full Text] [Related]

  • 4. [Eosinophilic lung infiltration during malaria prophylaxis with pyrimethamine-sulfadoxine (Fansidar)].
    Buser P, Räber J.
    Schweiz Med Wochenschr; 1985 Aug 24; 115(34):1174-6. PubMed ID: 4048913
    [Abstract] [Full Text] [Related]

  • 5. [Acute hepatitis following administration of fansidar].
    Meier P, Schmid M, Stäubli M.
    Schweiz Med Wochenschr; 1990 Feb 17; 120(7):221-5. PubMed ID: 2309111
    [Abstract] [Full Text] [Related]

  • 6. [Is the use of Fansidar as an antimalarial justified?].
    Olsen VV.
    Ugeskr Laeger; 1985 Feb 11; 147(7):624-5. PubMed ID: 3976083
    [No Abstract] [Full Text] [Related]

  • 7. Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine (Fansidar).
    Selby CD, Ladusans EJ, Smith PG.
    Br Med J (Clin Res Ed); 1985 Jan 12; 290(6462):113-4. PubMed ID: 3155635
    [No Abstract] [Full Text] [Related]

  • 8. [Pruritus, exanthema, icterus and fever].
    Groth H, Rhyner K, Vetter W.
    Schweiz Rundsch Med Prax; 1987 May 12; 76(20):570-4. PubMed ID: 3629058
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fansidar and hepatic granulomas.
    Lazar HP, Murphy RL, Phair JP.
    Ann Intern Med; 1985 May 12; 102(5):722. PubMed ID: 3985527
    [No Abstract] [Full Text] [Related]

  • 11. Severe cutaneous adverse reactions to sulfadoxine-pyrimethamine in Switzerland.
    Steffen R, Somaini B.
    Lancet; 1986 Mar 15; 1(8481):610. PubMed ID: 2869315
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adverse reactions to Fansidar and updated recommendations for its use in the prevention of malaria.
    Centers for Disease Control (CDC).
    MMWR Morb Mortal Wkly Rep; 1985 Jan 04; 33(51-52):713-4. PubMed ID: 3917533
    [No Abstract] [Full Text] [Related]

  • 14. Stevens-Johnson syndrome due to pyrimethamine/sulfadoxine during presumptive self-therapy of malaria.
    Phillips-Howard PA, Behrens RH, Dunlop J.
    Lancet; 1989 Sep 30; 2(8666):803-4. PubMed ID: 2571042
    [No Abstract] [Full Text] [Related]

  • 15. Sulfadoxine specific lymphocyte transformation in a patient with eosinophilic pneumonia induced by sulfadoxine-pyrimethamine (Fansidar).
    Daniel PT, Holzschuh J, Berg PA.
    Thorax; 1989 Apr 30; 44(4):307-9. PubMed ID: 2763233
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Serious side effects of sulfadoxine/pyrimethamine as antimalarials].
    Christensen PK, Loft S, Olsen VV.
    Ugeskr Laeger; 1983 Jan 24; 145(4):245. PubMed ID: 6845486
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Unusual pulmonary reaction during short term prophylaxis with pyrimethamine-sulfadoxine (Fansidar).
    Svanbom M, Rombo L, Gustafsson L.
    Br Med J (Clin Res Ed); 1984 Jun 23; 288(6434):1876. PubMed ID: 6428585
    [No Abstract] [Full Text] [Related]

  • 20. Adverse reactions to sulphadoxine-pyrimethamine in Swedish travellers: implications for prophylaxis.
    Hellgren U, Rombo L, Berg B, Carlson J, Wiholm BE.
    Br Med J (Clin Res Ed); 1987 Aug 08; 295(6594):365-6. PubMed ID: 2958104
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.